banner
Pawg khoom
Tiv tauj peb

Hu rau:Errol Zhou (Mr.)

Tel: ntxiv 86-551-65523315

Mobile/WhatsApp: ntxiv 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Email:sales@homesunshinepharma.com

Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

APIs thiab Intermediates
Pimavanserin CAS 706779-91-1

Pimavanserin CAS 706779-91-1

CAS Tsis Yog: 706779-91-1
Cov mis mos molecular: C25H34FN3O2
Molecular phaus: 427.55500
EINECS NO: Tsis yog
MDL TSIS YOG: MFCD09953792

Txhawb tshuaj

Khoom Piav Qhia:

Khoom Lub Npe: Pimavanserin CAS TSIS TAU: 706779-91-1

Lub ntsiab lus:

N-[(4-Fluorophenyl) Methyl] -N- (1-Methyl-4-piperidinyl) -N'-[[4- (2-Methylpropoxy) phenyl] Methyl] urea;

1-[(4-fluorophenyl) Methyl] -1- (1-Methylpiperidin-4-yl) -3-{[4- (2-Methylpropoxy) phenyl] Methyl} urea;

N- (1-methylpiperidin-4-yl) -N- (4-fluorophenylmethyl) -N'-( 4- (2-methylpropyloxy) phenylmethyl) carbamide;

Tshuaj& Lub Cev Muaj Zog:

Tshwm sim: daj daj rau daj txiv kab ntxwv tawv

Kev Ntsuas: ≥99.00%

Ceev: 1.15 ± 0.1 g/cm3 (calc.)

Kub Point: 604.2 ± 55.0 ℃ (760 mmHg, calc.)

Melting Point: 100-103 ℃

Flash Point: 319.222 ℃

Refractive Index: 1.576

Soluble: Methanol (Me ntsis)

Cia Li Cas: Cov tub yees

Cov Ntaub Ntawv Kev Nyab Xeeb:

Tus lej phom sij: Xi

Cov Lus Hais Txog Kev Nyab Xeeb: S24/25

Tus lej HS: 29339900

Pimavanserin (INN), lossis pimavanserin tartate (USAN), ua lag luam nyob rau hauv lub npe lag luam Nuplazid, yog cov tshuaj tsis yog-dopaminergic atypical antipsychotic tsim los ntawm Acadia Pharmaceuticals rau kev kho mob Parkinson' kab mob kev puas hlwb thiab schizophrenia. Pimavanserin muaj cov txheej txheem tshwj xeeb ntawm kev ua haujlwm txheeb ze rau lwm yam tshuaj tiv thaiv kab mob, coj tus yam ntxwv hloov pauv ntawm agotonist ntawm serotonin 5-HT2A tus txais, nrog 40-xaiv xaiv rau qhov chaw no ntau dua 5-HT2C tus txais thiab tsis muaj kev sib raug zoo lossis ua haujlwm ntawm 5- HT2B receptor lossis dopamine receptors. Cov tshuaj tau ua tiav qhov kev cia siab rau Phase III kev sim tshuaj rau kev kho mob Parkinson' tus kab mob kev puas siab puas ntsws, thiab tau ua tiav Phase II kev sim rau kev kho tus mob schizophrenia nrog rau kev siv tshuaj tiv thaiv kab mob.

Pimavanserin xav kom txhim kho kev ua haujlwm tau zoo thiab muaj txiaj ntsig zoo ntawm kev siv tshuaj tiv thaiv kab mob. Cov txiaj ntsig ntawm kev sim tshuaj ntsuam xyuas qhov ua tau zoo, ua siab ntev thiab nyab xeeb ntawm kev txiav txim siab pimavanserin rau risperidone thiab haloperidol tau tshaj tawm thaum lub Kaum Ib Hlis 2012, thiab cov txiaj ntsig tau pom tias pimavanserin ua rau muaj zog tiv thaiv kev tiv thaiv kab mob ntawm kev siv tshuaj tiv thaiv kab mob ntawm risperidone thiab txhim kho kev tiv taus ntawm kev kho haloperidol los ntawm kev txo qis qhov tshwm sim ntawm cov tsos mob extrapyramidal.

Thaum lub Cuaj Hlis 2, 2014, Tebchaws Meskas Cov Khoom Noj thiab Tshuaj Yeeb Tshuaj tau tso cai Kev Kho Mob Li Cas rau Acadia' Daim Ntawv Thov Tshuaj Tshiab rau pimavanserin. Nws tau pom zoo los ntawm FDA los kho qhov kev xav tsis meej thiab cuam tshuam nrog kev puas siab puas ntsws tau ntsib los ntawm qee tus neeg nrog Parkinson' tus kab mob thaum lub Plaub Hlis 29, 2016.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.


Cim npe nrov: pimavanserin cas 706779-91-1, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

Xa kev nug